"Designing Growth Strategies is in our DNA"

Sexually Transmitted Diseases Testing Market Size, Share & COVID-19 Impact Analysis, By Product Type (Instruments and Reagents & Kits), By Application (Chlamydia, Syphilis, Genital Herpes, Gonorrhea, Human Immunodeficiency Virus, Human Papillomavirus, and Others), By Setting (Laboratory Testing and Point-of-Care), By End User (Hospital & Clinics, Diagnostic Centers, and Others), and Regional Forecast, 2023-2030

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI101095

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Diseases, By Key Countries, 2022
    2. Key Industry Developments
    3. Overview of Regulatory Scenario, By Key Countries/Regions
    4. Technological Advancements in Sexually Transmitted Diseases Testing Market
    5. Impact of COVID-19 on Global Sexually Transmitted Diseases Testing Market
  5. Global Sexually Transmitted Diseases Testing Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Kits
    2. Market Analysis, Insights and Forecast – By Application
      1. Chlamydia
      2. Syphilis
      3. Genital Herpes
      4. Gonorrhea
      5. Human Immunodeficiency Virus
      6. Human Papillomavirus (HPV)
      7. Others
    3. Market Analysis, Insights and Forecast – By Setting
      1. Laboratory Testing
      2. Point-of Care (POC)
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals and Clinics
      2. Diagnostic Centers
      3. Others
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Sexually Transmitted Diseases Testing Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Kits
    2. Market Analysis, Insights and Forecast – By Application
      1. Chlamydia
      2. Syphilis
      3. Genital Herpes
      4. Gonorrhea
      5. Human Immunodeficiency Virus
      6. Human Papillomavirus (HPV)
      7. Others
    3. Market Analysis, Insights and Forecast – By Setting
      1. Laboratory Testing
      2. Point-of Care (POC)
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals and Clinics
      2. Diagnostic Centers
      3. Others
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Sexually Transmitted Diseases Testing Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Kits
    2. Market Analysis, Insights and Forecast – By Application
      1. Chlamydia
      2. Syphilis
      3. Genital Herpes
      4. Gonorrhea
      5. Human Immunodeficiency Virus
      6. Human Papillomavirus (HPV)
      7. Others
    3. Market Analysis, Insights and Forecast – By Setting
      1. Laboratory Testing
      2. Point-of Care (POC)
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals and Clinics
      2. Diagnostic Centers
      3. Others
    5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. U.K
      2. Germany
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Sexually Transmitted Diseases Testing Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Kits
    2. Market Analysis, Insights and Forecast – By Application
      1. Chlamydia
      2. Syphilis
      3. Genital Herpes
      4. Gonorrhea
      5. Human Immunodeficiency Virus
      6. Human Papillomavirus (HPV)
      7. Others
    3. Market Analysis, Insights and Forecast – By Setting
      1. Laboratory Testing
      2. Point-of Care (POC)
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals and Clinics
      2. Diagnostic Centers
      3. Others
    5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Sexually Transmitted Diseases Testing Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Kits
    2. Market Analysis, Insights and Forecast – By Application
      1. Chlamydia
      2. Syphilis
      3. Genital Herpes
      4. Gonorrhea
      5. Human Immunodeficiency Virus
      6. Human Papillomavirus (HPV)
      7. Others
    3. Market Analysis, Insights and Forecast – By Setting
      1. Laboratory Testing
      2. Point-of Care (POC)
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals and Clinics
      2. Diagnostic Centers
      3. Others
    5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Sexually Transmitted Diseases Testing Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Kits
    2. Market Analysis, Insights and Forecast – By Application
      1. Chlamydia
      2. Syphilis
      3. Genital Herpes
      4. Gonorrhea
      5. Human Immunodeficiency Virus
      6. Human Papillomavirus (HPV)
      7. Others
    3. Market Analysis, Insights and Forecast – By Setting
      1. Laboratory Testing
      2. Point-of Care (POC)
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals and Clinics
      2. Diagnostic Centers
      3. Others
    5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2022)
    2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
      1. Abbott
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      2. F. Hoffmann-La Roche Ltd
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      3. Becton, Dickinson and Company (BD)
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      4. Hologic, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      5. Danaher Corporation
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      6. Thermo Fisher Scientific Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      7. bioMérieux, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      8. Bio-Rad Laboratories, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      9. DiaSorin Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
Read Less

Figure 01: Global Sexually Transmitted Diseases Testing Market Value Share (%), By Product Type, 2022 & 2030

Figure 02: Global Sexually Transmitted Diseases Testing Market Value Share (%), By Application, 2022 & 2030

Figure 03: Global Sexually Transmitted Diseases Testing Market Value Share (%), By Setting, 2022 & 2030

Figure 04: Global Sexually Transmitted Diseases Testing Market Value Share (%), By End User, 2022 & 2030

Figure 05: Global Sexually Transmitted Diseases Testing Market Value Share (%), By Region, 2022 & 2030

Figure 06: North America Sexually Transmitted Diseases Testing Market Value (USD billion), by Product Type, 2022 & 2030

Figure 07: North America Sexually Transmitted Diseases Testing Market Value Share (%), by Product Type, 2022

Figure 08: North America Sexually Transmitted Diseases Testing Market Value (USD billion), by Application, 2022 & 2030

Figure 09: North America Sexually Transmitted Diseases Testing Market Value Share (%), by Application, 2022

Figure 10: North America Sexually Transmitted Diseases Testing Market Value (USD billion), by Setting, 2022 & 2030

Figure 11: North America Sexually Transmitted Diseases Testing Market Value Share (%), by Setting, 2022

Figure 12: North America Sexually Transmitted Diseases Testing Market Value (USD billion), by End User, 2022 & 2030

Figure 13: North America Sexually Transmitted Diseases Testing Market Value Share (%), by End User, 2022

Figure 14: North America Sexually Transmitted Diseases Testing Market Value (USD billion), by Country, 2022 & 2030

Figure 15: North America Sexually Transmitted Diseases Testing Market Value Share (%), by Country, 2022

Figure 16: Europe Sexually Transmitted Diseases Testing Market Value (USD billion), by Product Type, 2022 & 2030

Figure 17: Europe Sexually Transmitted Diseases Testing Market Value Share (%), by Product Type, 2022

Figure 18: Europe Sexually Transmitted Diseases Testing Market Value (USD billion), by Application, 2022 & 2030

Figure 19: Europe Sexually Transmitted Diseases Testing Market Value Share (%), by Application, 2022

Figure 20: Europe Sexually Transmitted Diseases Testing Market Value (USD billion), by Setting, 2022 & 2030

Figure 21: Europe Sexually Transmitted Diseases Testing Market Value Share (%), by Setting, 2022

Figure 22: Europe Sexually Transmitted Diseases Testing Market Value (USD billion), by End User, 2022 & 2030

Figure 23: Europe Sexually Transmitted Diseases Testing Market Value Share (%), by End User, 2022

Figure 24: Europe Sexually Transmitted Diseases Testing Market Value (USD billion), by Country/Sub-Region, 2022 & 2030

Figure 25: Europe Sexually Transmitted Diseases Testing Market Value Share (%), by Country/Sub-Region, 2022

Figure 26: Asia Pacific Sexually Transmitted Diseases Testing Market Value (USD billion), by Product Type, 2022 & 2030

Figure 27: Asia Pacific Sexually Transmitted Diseases Testing Market Value Share (%), by Product Type, 2022

Figure 28: Asia Pacific Sexually Transmitted Diseases Testing Market Value (USD billion), by Application, 2022 & 2030

Figure 29: Asia Pacific Sexually Transmitted Diseases Testing Market Value Share (%), by Application, 2022

Figure 30: Asia Pacific Sexually Transmitted Diseases Testing Market Value (USD billion), by Setting, 2022 & 2030

Figure 31: Asia Pacific Sexually Transmitted Diseases Testing Market Value Share (%), by Setting, 2022

Figure 32: Asia Pacific Sexually Transmitted Diseases Testing Market Value (USD billion), by End User, 2022 & 2030

Figure 33: Asia Pacific Sexually Transmitted Diseases Testing Market Value Share (%), by End User, 2022

Figure 34: Asia Pacific Sexually Transmitted Diseases Testing Market Value (USD billion), by Country/Sub-Region, 2022 & 2030

Figure 35: Asia Pacific Sexually Transmitted Diseases Testing Market Value Share (%), by Country/Sub-Region, 2022

Figure 36: Latin America Sexually Transmitted Diseases Testing Market Value (USD billion), by Product Type, 2022 & 2030

Figure 37: Latin America Sexually Transmitted Diseases Testing Market Value Share (%), by Product Type, 2022

Figure 38: Latin America Sexually Transmitted Diseases Testing Market Value (USD billion), by Application, 2022 & 2030

Figure 39: Latin America Sexually Transmitted Diseases Testing Market Value Share (%), by Application, 2022

Figure 40: Latin America Sexually Transmitted Diseases Testing Market Value (USD billion), by Setting, 2022 & 2030

Figure 41: Latin America Sexually Transmitted Diseases Testing Market Value Share (%), by Setting, 2022

Figure 42: Latin America Sexually Transmitted Diseases Testing Market Value (USD billion), by End User, 2022 & 2030

Figure 43: Latin America Sexually Transmitted Diseases Testing Market Value Share (%), by End User, 2022

Figure 44: Latin America Sexually Transmitted Diseases Testing Market Value (USD billion), by Country/Sub-Region, 2022 & 2030

Figure 45: Latin America Sexually Transmitted Diseases Testing Market Value Share (%), by Country/Sub-Region, 2022

Figure 46: Middle East & Africa Sexually Transmitted Diseases Testing Market Value (USD billion), by Product Type, 2022 & 2030

Figure 47: Middle East & Africa Sexually Transmitted Diseases Testing Market Value Share (%), by Product Type, 2022

Figure 48: Middle East & Africa Sexually Transmitted Diseases Testing Market Value (USD billion), by Application, 2022 & 2030

Figure 49: Middle East & Africa Sexually Transmitted Diseases Testing Market Value Share (%), by Application, 2022

Figure 50: Middle East & Africa Sexually Transmitted Diseases Testing Market Value (USD billion), by Setting, 2022 & 2030

Figure 51: Middle East & Africa Sexually Transmitted Diseases Testing Market Value Share (%), by Setting, 2022

Figure 52: Middle East & Africa Sexually Transmitted Diseases Testing Market Value (USD billion), by End User, 2022 & 2030

Figure 53: Middle East & Africa Sexually Transmitted Diseases Testing Market Value Share (%), by End User, 2022

Figure 54: Middle East & Africa Sexually Transmitted Diseases Testing Market Value (USD billion), by Country/Sub-Region, 2022 & 2030

Figure 55: Middle East & Africa Sexually Transmitted Diseases Testing Market Value Share (%), by Country/Sub-Region, 2022

Table 01: Global Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Product Type, 2019–2030

Table 02: Global Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Application, 2019–2030

Table 03: Global Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Setting, 2019–2030

Table 04: Global Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By End User, 2019–2030

Table 05: Global Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Region, 2019–2030

Table 06: North America Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Product Type, 2019–2030

Table 07: North America Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Application, 2019–2030

Table 08: North America Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Setting, 2019–2030

Table 09: North America Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By End User, 2019–2030

Table 10: North America Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Country, 2019–2030

Table 11: Europe Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Product Type, 2019–2030

Table 12: Europe Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Application, 2019–2030

Table 13: Europe Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Setting, 2019–2030

Table 14: Europe Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By End User, 2019–2030

Table 15: Europe Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2019–2030

Table 16: Asia Pacific Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Product Type, 2019–2030

Table 17: Asia Pacific Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Application, 2019–2030

Table 18: Asia Pacific Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Setting, 2019–2030

Table 19: Asia Pacific Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By End User, 2019–2030

Table 20: Asia Pacific Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2019–2030

Table 21: Latin America Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Product Type, 2019–2030

Table 22: Latin America Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Application, 2019–2030

Table 23: Latin America Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Setting, 2019–2030

Table 24: Latin America Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By End User, 2019–2030

Table 25: Latin America Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2019–2030

Table 26: Middle East & Africa Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Product Type, 2019–2030

Table 27: Middle East & Africa Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Application, 2019–2030

Table 28: Middle East & Africa Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Setting, 2019–2030

Table 29: Middle East & Africa Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By End User, 2019–2030

Table 30: Middle East & Africa Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2019–2030

 

  • 2019-2030
  • 2022
  • 2019-2021
  • 162
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase